Description: RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Home Page: www.rxsight.com
RXST Technical Analysis
100 Columbia
Aliso Viejo,
CA
92656
United States
Phone:
949 521 7830
Officers
| Name | Title |
|---|---|
| Dr. Ronald M. Kurtz M.D. | Pres, CEO & Director |
| Ms. Shelley B. Thunen | CFO & Assistant Sec. |
| Dr. Ilya Goldshleger Ph.D. | Chief Operating Officer |
| Mr. Eric J. Weinberg | Chief Commercial Officer |
| Rebecca Williston | VP of Accounting & Fin. |
| Mr. Matt Haller Ph.D. | Chief Technology Officer |
| Steve Everly | VP of US Sales |
| Mr. Roy Freeman | VP of Marketing |
| Caroline Vaughn | VP of HR |
| Scott Gaines | Sr. VP of Commercial Operations & Bus. Process |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.5534 |
| Price-to-Sales TTM: | 8.0799 |
| IPO Date: | 2021-07-30 |
| Fiscal Year End: | December |
| Full Time Employees: | 221 |